Chemical Structure : Varlilumab
CAS No.: 1393344-72-3
货号: PC-Ab1082Not For Human Use, Lab Use Only.
Varlilumab (CDX-1127) is a novel, first-in-class fully human IgG1 kappa anti-CD27 monoclonal antibody that acts as an agonist of CD27 by interaction with the CD70-binding site. Varlilumab (CDX-1127) stimulates the CD27 pathway, which results in T-cell activation and antitumor activity in tumor models..
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥3580 | In stock | |
| 5 mg | ¥7580 | In stock | |
| 10 mg | ¥12800 | In stock | |
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Varlilumab (CDX-1127) is a novel, first-in-class fully human IgG1 kappa anti-CD27 monoclonal antibody that acts as an agonist of CD27 by interaction with the CD70-binding site. Varlilumab (CDX-1127) stimulates the CD27 pathway, which results in T-cell activation and antitumor activity in tumor models.
| 分子量 | ||
| 分子式 | Human IgG4P-Kappa | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             PBS, pH 7.0 Contains no stabilizers or preservatives  | 
                    |
| Chemical Name/SMILES | 
                             Varlilumab; CDX-1127; CDX1127; Anti-human TNFRSF7; 1F5; 1393344-72-3; anti human CD27; Cluster of differentiation 27  | 
                    |
1. 1, Ansell SM, et al. Blood Adv. 2020 May 12;4(9):1917-1926. 2, Burris HA, et al. J Clin Oncol. 2017 Jun 20;35(18):2028-2036. 3, Ramakrishna V, et al. J Immunother Cancer. 2015 Aug 18;3:37. 4, Turaj AH, et al. Cancer Cell. 2017 Dec 11;32(6):777-791.e6.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright